UniProt ID | ATG4D_HUMAN | |
---|---|---|
UniProt AC | Q86TL0 | |
Protein Name | Cysteine protease ATG4D | |
Gene Name | ATG4D | |
Organism | Homo sapiens (Human). | |
Sequence Length | 474 | |
Subcellular Localization |
Cysteine protease ATG4D: Cytoplasm . Cysteine protease ATG4D, mitochondrial: Cytoplasm . Mitochondrion matrix . Imported into mitochondrial matrix after cleavage by CASP3 during oxidative stress and cell death. |
|
Protein Description | Cysteine protease ATG4D: Cysteine protease required for the cytoplasm to vacuole transport (Cvt) and autophagy. Cleaves the C-terminal amino acid of ATG8 family proteins MAP1LC3 and GABARAPL2, to reveal a C-terminal glycine. Exposure of the glycine at the C-terminus is essential for ATG8 proteins conjugation to phosphatidylethanolamine (PE) and insertion to membranes, which is necessary for autophagy. Has also an activity of delipidating enzyme for the PE-conjugated forms.; Cysteine protease ATG4D, mitochondrial: Plays a role as an autophagy regulator that links mitochondrial dysfunction with apoptosis. The mitochondrial import of ATG4D during cellular stress and differentiation may play important roles in the regulation of mitochondrial physiology, ROS, mitophagy and cell viability.. | |
Protein Sequence | MNSVSPAAAQYRSSSPEDARRRPEARRPRGPRGPDPNGLGPSGASGPALGSPGAGPSEPDEVDKFKAKFLTAWNNVKYGWVVKSRTSFSKISSIHLCGRRYRFEGEGDIQRFQRDFVSRLWLTYRRDFPPLPGGCLTSDCGWGCMLRSGQMMLAQGLLLHFLPRDWTWAEGMGLGPPELSGSASPSRYHGPARWMPPRWAQGAPELEQERRHRQIVSWFADHPRAPFGLHRLVELGQSSGKKAGDWYGPSLVAHILRKAVESCSDVTRLVVYVSQDCTVYKADVARLVARPDPTAEWKSVVILVPVRLGGETLNPVYVPCVKELLRCELCLGIMGGKPRHSLYFIGYQDDFLLYLDPHYCQPTVDVSQADFPLESFHCTSPRKMAFAKMDPSCTVGFYAGDRKEFETLCSELTRVLSSSSATERYPMFTLAEGHAQDHSLDDLCSQLAQPTLRLPRTGRLLRAKRPSSEDFVFL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Phosphorylation | -----MNSVSPAAAQ -----CCCCCHHHHH | 23.75 | 22199227 | |
5 | Phosphorylation | ---MNSVSPAAAQYR ---CCCCCHHHHHHH | 14.51 | 22199227 | |
13 | Phosphorylation | PAAAQYRSSSPEDAR HHHHHHHCCCHHHHH | 30.18 | 28102081 | |
14 | Phosphorylation | AAAQYRSSSPEDARR HHHHHHCCCHHHHHH | 40.70 | 28102081 | |
15 | Phosphorylation | AAQYRSSSPEDARRR HHHHHCCCHHHHHHC | 33.29 | 28102081 | |
45 | Phosphorylation | GLGPSGASGPALGSP CCCCCCCCCCCCCCC | 49.16 | 23532336 | |
51 | Phosphorylation | ASGPALGSPGAGPSE CCCCCCCCCCCCCCC | 22.47 | 23532336 | |
64 | Ubiquitination | SEPDEVDKFKAKFLT CCCCHHHHHHHHHHH | 54.67 | - | |
66 | Ubiquitination | PDEVDKFKAKFLTAW CCHHHHHHHHHHHHH | 57.30 | - | |
68 | Ubiquitination | EVDKFKAKFLTAWNN HHHHHHHHHHHHHCC | 41.31 | - | |
71 | O-linked_Glycosylation | KFKAKFLTAWNNVKY HHHHHHHHHHCCCCE | 32.53 | 30379171 | |
87 | Phosphorylation | WVVKSRTSFSKISSI EEEECCCCCCCCCEE | 26.81 | 24719451 | |
92 | Phosphorylation | RTSFSKISSIHLCGR CCCCCCCCEEEECCC | 27.29 | 23312004 | |
93 | Phosphorylation | TSFSKISSIHLCGRR CCCCCCCEEEECCCE | 19.94 | 23312004 | |
101 | Phosphorylation | IHLCGRRYRFEGEGD EEECCCEEECCCCCH | 20.49 | 19664994 | |
167 | Phosphorylation | HFLPRDWTWAEGMGL HHCCCCCHHHCCCCC | 21.06 | - | |
180 | Phosphorylation | GLGPPELSGSASPSR CCCCCHHCCCCCCCC | 29.10 | 24719451 | |
182 | Phosphorylation | GPPELSGSASPSRYH CCCHHCCCCCCCCCC | 23.38 | 28348404 | |
184 | Phosphorylation | PELSGSASPSRYHGP CHHCCCCCCCCCCCC | 25.71 | 28348404 | |
241 | Ubiquitination | ELGQSSGKKAGDWYG HHHHCCCCCCCCCCC | 41.20 | 21906983 | |
258 | Ubiquitination | LVAHILRKAVESCSD HHHHHHHHHHHCCCC | 54.03 | - | |
264 | Phosphorylation | RKAVESCSDVTRLVV HHHHHCCCCCCEEEE | 44.38 | 19664994 | |
298 | Ubiquitination | PDPTAEWKSVVILVP CCCCCCCEEEEEEEE | 25.52 | - | |
322 | Ubiquitination | PVYVPCVKELLRCEL CCHHHHHHHHHCCCH | 49.73 | - | |
388 | Ubiquitination | PRKMAFAKMDPSCTV CCCEEEECCCCCCEE | 37.06 | - | |
398 | Phosphorylation | PSCTVGFYAGDRKEF CCCEEEEEECCHHHH | 12.07 | 22817900 | |
403 | Ubiquitination | GFYAGDRKEFETLCS EEEECCHHHHHHHHH | 72.06 | - | |
407 | Phosphorylation | GDRKEFETLCSELTR CCHHHHHHHHHHHHH | 38.08 | 24719451 | |
410 | Phosphorylation | KEFETLCSELTRVLS HHHHHHHHHHHHHHC | 38.46 | 24719451 | |
464 | Ubiquitination | TGRLLRAKRPSSEDF CCCCEECCCCCCCCC | 59.41 | - | |
467 | Phosphorylation | LLRAKRPSSEDFVFL CEECCCCCCCCCCCC | 50.85 | 25159151 | |
468 | Phosphorylation | LRAKRPSSEDFVFL- EECCCCCCCCCCCC- | 43.82 | 22617229 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ATG4D_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ATG4D_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ATG4D_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
GBRL2_HUMAN | GABARAPL2 | physical | 19549685 | |
GBRL1_HUMAN | GABARAPL1 | physical | 19549685 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...